乳腺癌患者术前乳腺MRI检出的同步BI-RADS 3类病灶:随访是否足够?
本研究分析99例乳腺癌患者术前MRI检出的同步BI-RADS 3类病灶在随访而非活检下的恶性率,99例中96例行二次超声均未发现病灶,随访中位39个月,6个月和30个月恶性率分别为1.0%和2.2%,作者认为可对这类病灶进行监测并建议2年后继续年度随访。
要点
- 术前MRI检出的同步BI-RADS 3类病灶恶性率低,6个月为1.0%、30个月为2.2%。
- 二次超声在96例中均未发现病灶,随访中位39个月。
- 作者认为可对这类病灶监测,并建议2年后继续年度随访。
核心结论
- 对术前乳腺癌患者MRI检出的同步BI-RADS 3类病灶可提议监测,继续随访超过2年可能有益。
研究设计与样本
- 单中心研究,纳入99例在本机构治疗、术前乳腺MRI检出同步BI-RADS 3类病灶的患者,分析病灶特征、二次超声率、集体决策率和监测期间活检率。
诊断标准与关键数值
- 随访的同步BI-RADS 3类病灶恶性发生率6个月为1.0%(95%CI [0.1%; 7.1%]),30个月为2.2%(95%CI [0.6%; 8.6%])。
临床应用与阅片要点
- 作者认为可对二次超声未检出的MRI BI-RADS 3类病灶提议随访,可能在集体决策后进行;作者建议因癌可能发生于2年之后,应每年继续随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to analyze the rate of malignancy of synchronous Breast Imaging Reporting and Data System (BI-RADS) category 3 lesions identified by preoperative magnetic resonance imaging (MRI) in patients with breast cancer that were followed up rather than biopsied.
METHODS: From electronic medical records, we identified 99 patients treated in our institution for whom preoperative breast MRI identified synchronous BI-RADS 3 lesions. Lesion characteristics, rate of second-look ultrasonography (US), rate of collegial decision-making, and rate of biopsies performed during the period of monitoring were analyzed.
RESULTS: Second-look US was performed in 96 of 99 patients and did not reveal any lesion. Collegial decision-making for follow-up validation was asked in 32%. The median time to last MRI was 24.4 months (interquartile range [IQR] [19.3; 36.3]). The median follow-up was 39 months (IQR [28; 52]). Two cancers were diagnosed, one at 5 months and one at 26 months of follow-up. The incidence of malignancy of followed up synchronous BI-RADS category 3 lesions was 1.0% (95% CI [0.1%; 7.1%]) at 6 months and 2.2% (95% CI [0.6%; 8.6%]) at 30 months.
CONCLUSION: Monitoring could be proposed for synchronous BI-RADS category 3 lesions detected in preoperative breast cancer patients. A continued follow-up beyond 2 years could be of benefit.
KEY POINTS: • Follow-up can be proposed for MRI BI-RADS category 3 lesions not detected at second-look ultrasound, possibly after a collegial decision. • Follow-up should be continued annually since cancer may occur beyond 2 years.
引用
- Martin E, Boudier J, Salleron J, et al. Synchronous BI-RADS category 3 lesions detected by preoperative breast MRI in patients with breast cancer: may follow-up be adequate? Eur Radiol. 2021. PMID: 33993330. doi:10.1007/s00330-021-07983-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。